MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 186 filers reported holding MEDICINES CO in Q1 2016. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $41,435,000 | +64.8% | 487,815 | -3.0% | 0.02% | +60.0% |
| Q3 2019 | $25,142,000 | +51.9% | 502,842 | +10.8% | 0.01% | +42.9% |
| Q2 2019 | $16,547,000 | +79.3% | 453,697 | +66.9% | 0.01% | -85.1% |
| Q4 2016 | $9,228,000 | -24.3% | 271,883 | -15.9% | 0.05% | -33.8% |
| Q3 2016 | $12,196,000 | +9.0% | 323,171 | -2.9% | 0.07% | +2.9% |
| Q2 2016 | $11,194,000 | +39.5% | 332,870 | +31.8% | 0.07% | +64.3% |
| Q1 2016 | $8,026,000 | -21.6% | 252,637 | -7.9% | 0.04% | -20.8% |
| Q4 2015 | $10,239,000 | +10.9% | 274,216 | +12.8% | 0.05% | +1.9% |
| Q3 2015 | $9,229,000 | +4424.0% | 243,112 | +4511.4% | 0.05% | +5100.0% |
| Q4 2013 | $204,000 | – | 5,272 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 4,202,000 | $356,917,000 | 29.62% |
| SYQUANT CAPITAL SAS | 505,030 | $42,897,000 | 22.09% |
| Moab Capital Partners | 521,987 | $44,338,000 | 17.51% |
| Antipodean Advisors LLC | 321,000 | $27,266,000 | 15.60% |
| RAMIUS ADVISORS LLC | 419,826 | $35,660,000 | 15.34% |
| DLD Asset Management, LP | 3,275,900 | $278,255,000 | 15.00% |
| Foresite Capital Management IV, LLC | 403,217 | $34,249,000 | 14.78% |
| WHITE SQUARE CAPITAL LLP | 239,331 | $20,329,000 | 14.70% |
| Davide Leone & Partners Investment Co Ltd. | 1,146,192 | $97,358,000 | 12.50% |
| Quad Capital Management Advisors LLC | 8,640 | $734,000 | 11.19% |